Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.310535713975444e-61,79.94419076610858,11161.824804107855,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'MRPL19', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.268021427864013e-59,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.6113354351568337e-25,17.43978243978244,995.5946966452161,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.8369223960787904e-23,0,0,40
3,Nonalcoholic fatty liver disease WP4396,1.5369285354819991e-15,8.852199703410776,301.93959494633896,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS', 'BAX']",1.1680656869663193e-13,0,0,32
4,Mitochondrial CIV Assembly WP4922,3.014148840244645e-11,22.844827586206897,553.4186563243047,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",1.7180648389394476e-09,0,0,15
5,Oxidative phosphorylation WP623,2.627706747184076e-09,8.684854994629431,171.58802046586462,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",1.1982342767159388e-07,0,0,18
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.2463849580072058e-08,9.136178861788618,166.28241505286073,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'TMEM126B']",4.7362628404273817e-07,0,0,16
7,Mitochondrial complex III assembly WP4921,7.652640004060251e-07,63.013972055888225,887.4286018285262,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",2.492574172751053e-05,0,0,7
8,Cellular Proteostasis WP4918,5.737731063766009e-05,44.83101391650099,437.81347809612777,"['VBP1', 'PFDN1', 'PFDN4', 'PFDN5', 'PFDN6']",0.0016352533531733126,0,0,5
9,Pyrimidine metabolism WP4022,0.0023103496647222674,3.463855421686747,21.02683691348853,"['NT5C', 'POLD4', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.058528858172964104,0,0,10
10,Proteasome Degradation WP183,0.003427783211283644,4.4880239520958085,25.47331269377929,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMC1', 'HLA-B', 'PSMB10']",0.07815345721726709,0,0,7
11,mRNA Processing WP411,0.004875280206280425,4.889532777978993,26.029807650355792,"['LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SRSF9', 'LSM2']",0.1010512624574488,0,0,6
12,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.010226322148883308,inf,inf,"['ELOB', 'ELOC']",0.19430012082878284,0,0,2
13,Dual hijack model of Vif in HIV infection WP3300,0.053418534910972836,8.911067193675889,26.10584015090269,"['ELOB', 'ELOC']",0.9368789199770621,0,0,2
14,Eukaryotic Transcription Initiation WP405,0.07210884926206725,3.8223479490806223,10.051164010394013,"['POLR2I', 'POLR2J', 'POLR2K']",0.9963497212814001,0,0,3
15,Base Excision Repair WP4752,0.09195573267915351,3.343811881188119,7.97983312361204,"['POLD4', 'APEX1', 'POLE3']",0.9963497212814001,0,0,3
16,Insulin signaling in adipocytes (diabetic condition) WP3635,0.10121512834459837,inf,inf,['RPS6'],0.9963497212814001,0,0,1
17,Insulin signaling in adipocytes (normal condition) WP3634,0.10121512834459837,inf,inf,['RPS6'],0.9963497212814001,0,0,1
18,Mitochondrial CII Assembly WP4920,0.10121512834459837,inf,inf,['SDHAF1'],0.9963497212814001,0,0,1
19,Nucleotide Excision Repair WP4753,0.11376696755455158,2.9716171617161717,6.459116176538363,"['POLD4', 'POLE3', 'GTF2H5']",0.9963497212814001,0,0,3
20,DNA Repair Pathways Full Network WP4946,0.11571318252414868,2.1253431790211113,4.5836016314356405,"['POLD4', 'CENPX', 'APEX1', 'POLE3', 'GTF2H5']",0.9963497212814001,0,0,5
21,Gastric Cancer Network 2 WP2363,0.11656723479393523,4.453557312252965,9.571973056557695,"['S100A6', 'COL9A3']",0.9963497212814001,0,0,2
22,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.11656723479393523,4.453557312252965,9.571973056557695,"['EIF3D', 'EIF1']",0.9963497212814001,0,0,2
23,Selenium Micronutrient Network WP15,0.1365390716485984,1.8472317626047534,3.678105301773477,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SELENOH']",0.9963497212814001,0,0,6
24,VEGFA-VEGFR2 Signaling Pathway WP3888,0.16165590335669408,1.347547897554206,2.455616665607256,"['SET', 'RPS6', 'SARS', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9963497212814001,0,0,17
25,Serotonin and anxiety WP3947,0.19043210999555937,2.9677206851119893,4.921844640461667,"['POMC', 'CRH']",0.9963497212814001,0,0,2
26,MED and Pseudoachondroplasia genes WP4789,0.19220398420291282,8.895463510848126,14.670381104377023,['COL9A3'],0.9963497212814001,0,0,1
27,Peroxiredoxin 2 induced ovarian failure WP4873,0.19220398420291282,8.895463510848126,14.670381104377023,['BAX'],0.9963497212814001,0,0,1
28,Purine metabolism WP4792,0.19220398420291282,8.895463510848126,14.670381104377023,['APRT'],0.9963497212814001,0,0,1
29,Translation Factors WP107,0.2157503699575124,2.0554455445544555,3.1522995983591504,"['EEF1B2', 'EIF3D', 'EIF1']",0.9963497212814001,0,0,3
30,Non-small cell lung cancer WP4255,0.2157503699575124,2.0554455445544555,3.1522995983591504,"['CYCS', 'BAX', 'HRAS']",0.9963497212814001,0,0,3
31,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.22022048789169898,1.7821428571428573,2.696606722841838,"['POMC', 'RPS6', 'ZNF516', 'HRAS']",0.9963497212814001,0,0,4
32,TP53 network WP1742,0.22928382788156745,2.5431959345002824,3.7456052894673566,"['SUMO1', 'BAX']",0.9963497212814001,0,0,2
33,DNA Mismatch Repair WP531,0.22928382788156745,2.5431959345002824,3.7456052894673566,"['POLD4', 'POLE3']",0.9963497212814001,0,0,2
34,Glycosylation and related congenital defects WP4521,0.2685775744946617,2.224802371541502,2.924759656966255,"['DPM2', 'DPM3']",0.9963497212814001,0,0,2
35,MET in type 1 papillary renal cell carcinoma WP4205,0.2685775744946617,2.224802371541502,2.924759656966255,"['RPL11', 'HRAS']",0.9963497212814001,0,0,2
36,Nanomaterial induced apoptosis WP2507,0.2685775744946617,2.224802371541502,2.924759656966255,"['BAX', 'CYCS']",0.9963497212814001,0,0,2
37,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2721996984213435,1.7805940594059406,2.3169433496809013,"['APEX1', 'RPS6', 'HRAS']",0.9963497212814001,0,0,3
38,Endometrial cancer WP4155,0.2721996984213435,1.7805940594059406,2.3169433496809013,"['BAX', 'FGF1', 'HRAS']",0.9963497212814001,0,0,3
39,Modulators of TCR signaling and T cell activation WP5072,0.2721996984213435,1.7805940594059406,2.3169433496809013,"['NDUFB10', 'ELOB', 'RNF7']",0.9963497212814001,0,0,3
40,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.273997854554524,4.446745562130178,5.756912452913324,['IDH3B'],0.9963497212814001,0,0,1
41,Iron metabolism in placenta WP2007,0.273997854554524,4.446745562130178,5.756912452913324,['FTH1'],0.9963497212814001,0,0,1
42,Ciliary landscape WP4352,0.2866136725040057,1.356200642193873,1.6947355263109183,"['COPS6', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'COX6C', 'LSM4']",0.9963497212814001,0,0,7
43,Interleukin-11 Signaling Pathway WP2332,0.3078268701397117,1.9771629336846728,2.329528490765082,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
44,Leptin signaling pathway WP2034,0.3299645391043855,1.5704135119394291,1.7412275271306263,"['RPS6', 'BAX', 'HRAS']",0.9963497212814001,0,0,3
45,Type 2 papillary renal cell carcinoma WP4241,0.3466388443907564,1.7790513833992094,1.8848548342641824,"['ELOB', 'ELOC']",0.9963497212814001,0,0,2
46,Copper homeostasis WP3286,0.3466388443907564,1.7790513833992094,1.8848548342641824,"['COX17', 'ATOX1']",0.9963497212814001,0,0,2
47,IL-2 signaling pathway WP49,0.3466388443907564,1.7790513833992094,1.8848548342641824,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
48,Parkinson's disease pathway WP2371,0.3466388443907564,1.7790513833992094,1.8848548342641824,"['CYCS', 'PARK7']",0.9963497212814001,0,0,2
49,Serotonin and anxiety-related events WP3944,0.34752428545421543,2.9638395792241945,3.1325434923286792,['CRH'],0.9963497212814001,0,0,1
50,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.34752428545421543,2.9638395792241945,3.1325434923286792,['DLL3'],0.9963497212814001,0,0,1
51,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.34752428545421543,2.9638395792241945,3.1325434923286792,['COX8A'],0.9963497212814001,0,0,1
52,Glutathione metabolism WP100,0.34752428545421543,2.9638395792241945,3.1325434923286792,['GPX4'],0.9963497212814001,0,0,1
53,"GPCRs, Class B Secretin-like WP334",0.34752428545421543,2.9638395792241945,3.1325434923286792,['ADGRL2'],0.9963497212814001,0,0,1
54,Homologous recombination WP186,0.34752428545421543,2.9638395792241945,3.1325434923286792,['POLD4'],0.9963497212814001,0,0,1
55,MTHFR deficiency WP4288,0.34752428545421543,2.9638395792241945,3.1325434923286792,['CYCS'],0.9963497212814001,0,0,1
56,IL-18 signaling pathway WP4754,0.38512364286147405,1.1563135659521202,1.1033438196937986,"['NRN1', 'TMSB4X', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'BPGM', 'RPS11', 'RND2', 'ABCF1']",0.9963497212814001,0,0,10
57,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4136174348677391,2.222386587771203,1.961953554710514,['HRAS'],0.9963497212814001,0,0,1
58,Cancer immunotherapy by CTLA4 blockade WP4582,0.4136174348677391,2.222386587771203,1.961953554710514,['HLA-DRB1'],0.9963497212814001,0,0,1
59,Type II diabetes mellitus WP1584,0.4136174348677391,2.222386587771203,1.961953554710514,['SURF1'],0.9963497212814001,0,0,1
60,Fatty acid transporters WP5061,0.4136174348677391,2.222386587771203,1.961953554710514,['FABP6'],0.9963497212814001,0,0,1
61,Genes targeted by miRNAs in adipocytes WP1992,0.4136174348677391,2.222386587771203,1.961953554710514,['TMSB4X'],0.9963497212814001,0,0,1
62,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4136174348677391,2.222386587771203,1.961953554710514,['HRAS'],0.9963497212814001,0,0,1
63,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4136174348677391,2.222386587771203,1.961953554710514,['VEGFB'],0.9963497212814001,0,0,1
64,Purine metabolism and related disorders WP4224,0.4136174348677391,2.222386587771203,1.961953554710514,['APRT'],0.9963497212814001,0,0,1
65,RalA downstream regulated genes WP2290,0.4136174348677391,2.222386587771203,1.961953554710514,['HRAS'],0.9963497212814001,0,0,1
66,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.41602752309459023,1.333960396039604,1.1698884159127756,"['RPS6', 'BAX', 'HRAS']",0.9963497212814001,0,0,3
67,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.41602752309459023,1.333960396039604,1.1698884159127756,"['PSMC5', 'PSMD7', 'PSMC1']",0.9963497212814001,0,0,3
68,Kit receptor signaling pathway WP304,0.42176579683761395,1.4818840579710144,1.2793180690099188,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
69,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4576469239345687,1.3675889328063242,1.0689858735621516,"['IFI27L2', 'HRAS']",0.9963497212814001,0,0,2
70,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4576469239345687,1.3675889328063242,1.0689858735621516,"['NDUFA13', 'COPS6']",0.9963497212814001,0,0,2
71,Thermogenesis WP4321,0.4714301791784684,1.2121512151215121,0.9115186468874662,"['RPS6', 'ZNF516', 'HRAS']",0.9963497212814001,0,0,3
72,Apoptosis Modulation by HSP70 WP384,0.47302744884827896,1.7775147928994084,1.3306508815324727,['CYCS'],0.9963497212814001,0,0,1
73,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.47302744884827896,1.7775147928994084,1.3306508815324727,['RPS6'],0.9963497212814001,0,0,1
74,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.47302744884827896,1.7775147928994084,1.3306508815324727,['BAX'],0.9963497212814001,0,0,1
75,miR-509-3p alteration of YAP1/ECM axis WP3967,0.47302744884827896,1.7775147928994084,1.3306508815324727,['SPARC'],0.9963497212814001,0,0,1
76,miRNA regulation of p53 pathway in prostate cancer WP3982,0.47302744884827896,1.7775147928994084,1.3306508815324727,['BAX'],0.9963497212814001,0,0,1
77,Nanoparticle-mediated activation of receptor signaling WP2643,0.47302744884827896,1.7775147928994084,1.3306508815324727,['HRAS'],0.9963497212814001,0,0,1
78,Nucleotide metabolism WP404,0.47302744884827896,1.7775147928994084,1.3306508815324727,['NME2'],0.9963497212814001,0,0,1
79,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.47302744884827896,1.7775147928994084,1.3306508815324727,['ANAPC11'],0.9963497212814001,0,0,1
80,"Relationship between inflammation, COX-2 and EGFR WP4483",0.47302744884827896,1.7775147928994084,1.3306508815324727,['HRAS'],0.9963497212814001,0,0,1
81,Sleep regulation WP3591,0.5253359298513025,1.1847167325428194,0.7626227210634429,"['CRH', 'HCRTR1']",0.9963497212814001,0,0,2
82,Ferroptosis WP4313,0.5253359298513025,1.1847167325428194,0.7626227210634429,"['GPX4', 'FTH1']",0.9963497212814001,0,0,2
83,BDNF-TrkB Signaling WP3676,0.5264289060120321,1.4809335963182118,0.950224733802585,['HRAS'],0.9963497212814001,0,0,1
84,Cytokines and Inflammatory Response WP530,0.5264289060120321,1.4809335963182118,0.950224733802585,['HLA-DRB1'],0.9963497212814001,0,0,1
85,ERK Pathway in Huntington's Disease WP3853,0.5264289060120321,1.4809335963182118,0.950224733802585,['HRAS'],0.9963497212814001,0,0,1
86,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5264289060120321,1.4809335963182118,0.950224733802585,['H2AFZ'],0.9963497212814001,0,0,1
87,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5264289060120321,1.4809335963182118,0.950224733802585,['RPS6'],0.9963497212814001,0,0,1
88,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5264289060120321,1.4809335963182118,0.950224733802585,['SUPT4H1'],0.9963497212814001,0,0,1
89,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5264289060120321,1.4809335963182118,0.950224733802585,['BAX'],0.9963497212814001,0,0,1
90,Methionine De Novo and Salvage Pathway WP3580,0.5264289060120321,1.4809335963182118,0.950224733802585,['TXN'],0.9963497212814001,0,0,1
91,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.5264289060120321,1.4809335963182118,0.950224733802585,['HLA-DRB1'],0.9963497212814001,0,0,1
92,PDGFR-beta pathway WP3972,0.5264289060120321,1.4809335963182118,0.950224733802585,['HRAS'],0.9963497212814001,0,0,1
93,Pyrimidine metabolism and related diseases WP4225,0.5264289060120321,1.4809335963182118,0.950224733802585,['NT5C'],0.9963497212814001,0,0,1
94,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5264289060120321,1.4809335963182118,0.950224733802585,['BAX'],0.9963497212814001,0,0,1
95,22q11.2 copy number variation syndrome WP4657,0.5496618572653925,1.065980198019802,0.6379379759198073,"['RANBP1', 'MRPL40', 'EMC10']",0.9963497212814001,0,0,3
96,Androgen receptor signaling pathway WP138,0.5496618572653925,1.065980198019802,0.6379379759198073,"['SUMO1', 'BAG1', 'PARK7']",0.9963497212814001,0,0,3
97,Cytosolic DNA-sensing pathway WP4655,0.5569779393287957,1.1104249011857708,0.6498535719095573,"['POLR2K', 'POLR2L']",0.9963497212814001,0,0,2
98,Statin inhibition of cholesterol production WP430,0.5744284160646448,1.2690898844744998,0.7035577856856939,['APOC1'],0.9963497212814001,0,0,1
99,Biomarkers for pyrimidine metabolism disorders WP4584,0.5744284160646448,1.2690898844744998,0.7035577856856939,['NT5C'],0.9963497212814001,0,0,1
100,Cancer immunotherapy by PD-1 blockade WP4585,0.5744284160646448,1.2690898844744998,0.7035577856856939,['HLA-DRB1'],0.9963497212814001,0,0,1
101,MAPK Cascade WP422,0.5744284160646448,1.2690898844744998,0.7035577856856939,['HRAS'],0.9963497212814001,0,0,1
102,NOTCH1 regulation of endothelial cell calcification WP3413,0.5744284160646448,1.2690898844744998,0.7035577856856939,['DLL3'],0.9963497212814001,0,0,1
103,Overview of nanoparticle effects WP3287,0.5744284160646448,1.2690898844744998,0.7035577856856939,['BAX'],0.9963497212814001,0,0,1
104,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5744284160646448,1.2690898844744998,0.7035577856856939,['HRAS'],0.9963497212814001,0,0,1
105,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5744284160646448,1.2690898844744998,0.7035577856856939,['BAX'],0.9963497212814001,0,0,1
106,Genotoxicity pathway WP4286,0.5870913851390855,1.0448732852824925,0.5564731700713548,"['RPS27', 'TRIAP1']",0.9963497212814001,0,0,2
107,p53 transcriptional gene network WP4963,0.5870913851390855,1.0448732852824925,0.5564731700713548,"['SIVA1', 'BAX']",0.9963497212814001,0,0,2
108,TNF-alpha signaling pathway WP231,0.5978569863789092,0.9865786578657866,0.5074997187010375,"['BAX', 'TXN', 'HRAS']",0.9963497212814001,0,0,3
109,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6156610128950875,0.9866051822573562,0.47856149683553345,"['CYCS', 'BAX']",0.9963497212814001,0,0,2
110,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6175714555694615,1.110207100591716,0.5350759689198978,['HRAS'],0.9963497212814001,0,0,1
111,Alpha 6 Beta 4 signaling pathway WP244,0.6175714555694615,1.110207100591716,0.5350759689198978,['HRAS'],0.9963497212814001,0,0,1
112,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6175714555694615,1.110207100591716,0.5350759689198978,['HRAS'],0.9963497212814001,0,0,1
113,Galanin receptor pathway WP4970,0.6175714555694615,1.110207100591716,0.5350759689198978,['POMC'],0.9963497212814001,0,0,1
114,Histone Modifications WP2369,0.6175714555694615,1.110207100591716,0.5350759689198978,['SET'],0.9963497212814001,0,0,1
115,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6175714555694615,1.110207100591716,0.5350759689198978,['HRAS'],0.9963497212814001,0,0,1
116,7q11.23 copy number variation syndrome WP4932,0.6206535348285511,0.9511315417256011,0.45367287962566644,"['ATP5MC2', 'ATP5F1E', 'ATP5MC1']",0.9963497212814001,0,0,3
117,Oncostatin M Signaling Pathway WP2374,0.6426902769945472,0.9344705637611816,0.4131222922978223,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
118,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6563485182693841,0.9866316020162174,0.4154344107836358,['HRAS'],0.9963497212814001,0,0,1
119,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6563485182693841,0.9866316020162174,0.4154344107836358,['RPS6'],0.9963497212814001,0,0,1
120,Type II interferon signaling (IFNG) WP619,0.6563485182693841,0.9866316020162174,0.4154344107836358,['HLA-B'],0.9963497212814001,0,0,1
121,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6563485182693841,0.9866316020162174,0.4154344107836358,['HRAS'],0.9963497212814001,0,0,1
122,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6563485182693841,0.9866316020162174,0.4154344107836358,['FGF1'],0.9963497212814001,0,0,1
123,Interferon type I signaling pathways WP585,0.6563485182693841,0.9866316020162174,0.4154344107836358,['RPS6'],0.9963497212814001,0,0,1
124,Head and Neck Squamous Cell Carcinoma WP4674,0.6681977230079683,0.8875494071146245,0.357834321108771,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
125,Prolactin Signaling Pathway WP2037,0.6681977230079683,0.8875494071146245,0.357834321108771,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
126,Breast cancer pathway WP4262,0.6817415992624717,0.8652729384436701,0.33149002536178024,"['BAX', 'FGF1', 'HRAS', 'DLL3']",0.9963497212814001,0,0,4
127,Canonical and non-canonical Notch signaling WP3845,0.6912006468749374,0.8877712031558186,0.3278762111277175,['DLL3'],0.9963497212814001,0,0,1
128,Vitamin D-sensitive calcium signaling in depression WP4698,0.6912006468749374,0.8877712031558186,0.3278762111277175,['GPX4'],0.9963497212814001,0,0,1
129,Imatinib and Chronic Myeloid Leukemia WP3640,0.6912006468749374,0.8877712031558186,0.3278762111277175,['SKP2'],0.9963497212814001,0,0,1
130,Notch Signaling WP268,0.6912006468749374,0.8877712031558186,0.3278762111277175,['DLL3'],0.9963497212814001,0,0,1
131,One-carbon metabolism and related pathways WP3940,0.6912006468749374,0.8877712031558186,0.3278762111277175,['GPX4'],0.9963497212814001,0,0,1
132,PDGF Pathway WP2526,0.6912006468749374,0.8877712031558186,0.3278762111277175,['HRAS'],0.9963497212814001,0,0,1
133,Pregnane X receptor pathway WP2876,0.6912006468749374,0.8877712031558186,0.3278762111277175,['PSMC5'],0.9963497212814001,0,0,1
134,Regulation of Microtubule Cytoskeleton WP2038,0.6912006468749374,0.8877712031558186,0.3278762111277175,['PARD6A'],0.9963497212814001,0,0,1
135,Acute viral myocarditis WP4298,0.692213908190779,0.8450969320534538,0.31087757313474723,"['CYCS', 'BAX']",0.9963497212814001,0,0,2
136,Allograft Rejection WP2328,0.692213908190779,0.8450969320534538,0.31087757313474723,"['HLA-B', 'HLA-DRB1']",0.9963497212814001,0,0,2
137,DNA damage response WP707,0.692213908190779,0.8450969320534538,0.31087757313474723,"['CYCS', 'BAX']",0.9963497212814001,0,0,2
138,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.692213908190779,0.8450969320534538,0.31087757313474723,"['BAX', 'HRAS']",0.9963497212814001,0,0,2
139,Apoptosis WP254,0.7147787888485675,0.806503772906935,0.2708095872893343,"['CYCS', 'BAX']",0.9963497212814001,0,0,2
140,Melanoma WP4685,0.7147787888485675,0.806503772906935,0.2708095872893343,"['BAX', 'HRAS']",0.9963497212814001,0,0,2
141,miRNA regulation of DNA damage response WP1530,0.7147787888485675,0.806503772906935,0.2708095872893343,"['CYCS', 'BAX']",0.9963497212814001,0,0,2
142,Regulation of Actin Cytoskeleton WP51,0.7210995047741424,0.8061206120612061,0.2635838198179008,"['TMSB4X', 'BRK1', 'FGF1']",0.9963497212814001,0,0,3
143,Amyotrophic lateral sclerosis (ALS) WP2447,0.7225244102656868,0.8068854222700377,0.2622410492722574,['BAX'],0.9963497212814001,0,0,1
144,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7225244102656868,0.8068854222700377,0.2622410492722574,['RPS6'],0.9963497212814001,0,0,1
145,CAMKK2  Pathway WP4874,0.7225244102656868,0.8068854222700377,0.2622410492722574,['FIS1'],0.9963497212814001,0,0,1
146,Integrated Cancer Pathway WP1971,0.7225244102656868,0.8068854222700377,0.2622410492722574,['BAX'],0.9963497212814001,0,0,1
147,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7225244102656868,0.8068854222700377,0.2622410492722574,['CYCS'],0.9963497212814001,0,0,1
148,p38 MAPK Signaling Pathway WP400,0.7225244102656868,0.8068854222700377,0.2622410492722574,['HRAS'],0.9963497212814001,0,0,1
149,Corticotropin-releasing hormone signaling pathway WP2355,0.7359395119774402,0.7712665406427222,0.23647598896994762,"['POMC', 'CRH']",0.9963497212814001,0,0,2
150,Retinoblastoma gene in cancer WP2446,0.7359395119774402,0.7712665406427222,0.23647598896994762,"['H2AFZ', 'SKP2']",0.9963497212814001,0,0,2
151,EGF/EGFR signaling pathway WP437,0.7384945952435978,0.7822364589400117,0.23712833007378734,"['NDUFA13', 'NEDD8', 'HRAS']",0.9963497212814001,0,0,3
152,Hepatitis B infection WP4666,0.7384945952435978,0.7822364589400117,0.23712833007378734,"['CYCS', 'BAX', 'HRAS']",0.9963497212814001,0,0,3
153,Endothelin Pathways WP2197,0.7506763795749947,0.7394806048652203,0.2120687207102988,['RIIAD1'],0.9963497212814001,0,0,1
154,Heart Development WP1591,0.7506763795749947,0.7394806048652203,0.2120687207102988,['VEGFB'],0.9963497212814001,0,0,1
155,Oxidative Damage WP3941,0.7506763795749947,0.7394806048652203,0.2120687207102988,['CYCS'],0.9963497212814001,0,0,1
156,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7506763795749947,0.7394806048652203,0.2120687207102988,['BAX'],0.9963497212814001,0,0,1
157,ESC Pluripotency Pathways WP3931,0.755748556262449,0.738965744400527,0.20694481147148108,"['FGF1', 'HRAS']",0.9963497212814001,0,0,2
158,Aryl Hydrocarbon Receptor Pathway WP2873,0.7759771557111215,0.6824457593688363,0.17309021779309125,['BAX'],0.9963497212814001,0,0,1
159,TGF-beta Receptor Signaling WP560,0.7759771557111215,0.6824457593688363,0.17309021779309125,['HRAS'],0.9963497212814001,0,0,1
160,Bladder cancer WP2828,0.7759771557111215,0.6824457593688363,0.17309021779309125,['HRAS'],0.9963497212814001,0,0,1
161,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7759771557111215,0.6824457593688363,0.17309021779309125,['CYCS'],0.9963497212814001,0,0,1
162,IL-5 signaling pathway WP127,0.7759771557111215,0.6824457593688363,0.17309021779309125,['RPS6'],0.9963497212814001,0,0,1
163,Lung fibrosis WP3624,0.7759771557111215,0.6824457593688363,0.17309021779309125,['FGF1'],0.9963497212814001,0,0,1
164,MECP2 and Associated Rett Syndrome WP3584,0.7759771557111215,0.6824457593688363,0.17309021779309125,['RPS6'],0.9963497212814001,0,0,1
165,Small cell lung cancer WP4658,0.7915390951433178,0.6818181818181818,0.1593927321431532,"['CYCS', 'BAX']",0.9963497212814001,0,0,2
166,DNA damage response (only ATM dependent) WP710,0.7915390951433178,0.6818181818181818,0.1593927321431532,"['BAX', 'HRAS']",0.9963497212814001,0,0,2
167,Aryl Hydrocarbon Receptor Netpath WP2586,0.7987149912189513,0.6335587489433643,0.1423930280906378,['HRAS'],0.9963497212814001,0,0,1
168,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7987149912189513,0.6335587489433643,0.1423930280906378,['HRAS'],0.9963497212814001,0,0,1
169,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7987149912189513,0.6335587489433643,0.1423930280906378,['BAX'],0.9963497212814001,0,0,1
170,IL-3 signaling pathway WP286,0.7987149912189513,0.6335587489433643,0.1423930280906378,['HRAS'],0.9963497212814001,0,0,1
171,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7987149912189513,0.6335587489433643,0.1423930280906378,['BAX'],0.9963497212814001,0,0,1
172,Alzheimer's disease WP2059,0.8076394485829795,0.6564192651149173,0.14023711447483264,"['ATP5MD', 'CYCS']",0.9963497212814001,0,0,2
173,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.8191490483108957,0.591190006574622,0.11793603536276699,['RNF7'],0.9963497212814001,0,0,1
174,DNA Replication WP466,0.8191490483108957,0.591190006574622,0.11793603536276699,['POLD4'],0.9963497212814001,0,0,1
175,Notch Signaling Pathway Netpath WP61,0.8191490483108957,0.591190006574622,0.11793603536276699,['DLL3'],0.9963497212814001,0,0,1
176,Pathways affected in adenoid cystic carcinoma WP3651,0.8191490483108957,0.591190006574622,0.11793603536276699,['HRAS'],0.9963497212814001,0,0,1
177,TGF-beta Signaling Pathway WP366,0.836552845080311,0.6108763799918223,0.10902041144377543,"['PARD6A', 'SUMO1']",0.9963497212814001,0,0,2
178,Complement system WP2806,0.836552845080311,0.6108763799918223,0.10902041144377543,"['RPS19', 'TXN']",0.9963497212814001,0,0,2
179,Synaptic Vesicle Pathway WP2267,0.8375123296031298,0.5541173570019724,0.09825569824698607,['PARK7'],0.9963497212814001,0,0,1
180,Glioblastoma signaling pathways WP2261,0.8375123296031298,0.5541173570019724,0.09825569824698607,['HRAS'],0.9963497212814001,0,0,1
181,PPAR signaling pathway WP3942,0.8375123296031298,0.5541173570019724,0.09825569824698607,['FABP6'],0.9963497212814001,0,0,1
182,Prostaglandin Synthesis and Regulation WP98,0.8375123296031298,0.5541173570019724,0.09825569824698607,['S100A6'],0.9963497212814001,0,0,1
183,Myometrial relaxation and contraction pathways WP289,0.8430293214640238,0.6675651392632524,0.11398911024437891,"['GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9963497212814001,0,0,4
184,Ebola Virus Pathway on Host WP4217,0.8494860008699681,0.5903820816864295,0.09630537880916941,"['HLA-B', 'HLA-DRB1']",0.9963497212814001,0,0,2
185,AGE/RAGE pathway WP2324,0.8540143139393602,0.5214061956143404,0.08228171659339148,['CYCS'],0.9963497212814001,0,0,1
186,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8540143139393602,0.5214061956143404,0.08228171659339148,['HRAS'],0.9963497212814001,0,0,1
187,G Protein Signaling Pathways WP35,0.8540143139393602,0.5214061956143404,0.08228171659339148,['HRAS'],0.9963497212814001,0,0,1
188,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.85869719862049,0.6172691687773428,0.09403412077912535,"['SPARC', 'HRAS', 'DLL3']",0.9963497212814001,0,0,3
189,Differentiation Pathway WP2848,0.86884332696563,0.49232960771422307,0.06921783124552956,['FGF1'],0.9963497212814001,0,0,1
190,ErbB signaling pathway WP673,0.86884332696563,0.49232960771422307,0.06921783124552956,['HRAS'],0.9963497212814001,0,0,1
191,Folate Metabolism WP176,0.86884332696563,0.49232960771422307,0.06921783124552956,['GPX4'],0.9963497212814001,0,0,1
192,Integrin-mediated Cell Adhesion WP185,0.86884332696563,0.49232960771422307,0.06921783124552956,['HRAS'],0.9963497212814001,0,0,1
193,Apoptosis Modulation and Signaling WP1772,0.8725969895656845,0.5532361660079052,0.07539583699680937,"['CYCS', 'BAX']",0.9963497212814001,0,0,2
194,16p11.2 proximal deletion syndrome WP4949,0.8821686734425711,0.46631371327727605,0.05846268357377119,['SEZ6L2'],0.9963497212814001,0,0,1
195,Osteoblast differentiation WP4787,0.8828865926347765,0.5363516588813031,0.06680716925284802,"['FGF1', 'DLL3']",0.9963497212814001,0,0,2
196,Senescence and Autophagy in Cancer WP615,0.8924034526204628,0.520460358056266,0.05924761846391856,"['SPARC', 'HRAS']",0.9963497212814001,0,0,2
197,Integrated breast cancer pathway WP1984,0.8924034526204628,0.520460358056266,0.05924761846391856,"['BAX', 'FAU']",0.9963497212814001,0,0,2
198,Circadian rhythm related genes WP3594,0.8937192749171524,0.5988700564971752,0.06729117348967023,"['CAVIN3', 'CRH', 'RPS27A', 'HCRTR1']",0.9963497212814001,0,0,4
199,T-cell receptor (TCR) signaling pathway WP69,0.8941425549726525,0.4428994082840237,0.049556040949119355,['HRAS'],0.9963497212814001,0,0,1
200,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9011982170436877,0.5054771315640881,0.05258481068951085,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
201,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9049017946016191,0.42171503709965247,0.042141500971894105,['TMSB4X'],0.9963497212814001,0,0,1
202,Pancreatic adenocarcinoma pathway WP4263,0.9049017946016191,0.42171503709965247,0.042141500971894105,['BAX'],0.9963497212814001,0,0,1
203,Peptide GPCRs WP24,0.9049017946016191,0.42171503709965247,0.042141500971894105,['HCRTR1'],0.9963497212814001,0,0,1
204,Prader-Willi and Angelman Syndrome WP3998,0.9049017946016191,0.42171503709965247,0.042141500971894105,['POMC'],0.9963497212814001,0,0,1
205,Cell cycle WP179,0.9093192196260669,0.49132630654369785,0.04670502164198883,"['SKP2', 'ANAPC11']",0.9963497212814001,0,0,2
206,Gastrin signaling pathway WP4659,0.9093192196260669,0.49132630654369785,0.04670502164198883,"['RPS6', 'HRAS']",0.9963497212814001,0,0,2
207,Exercise-induced Circadian Regulation WP410,0.923255898541214,0.38487265243118085,0.030731633451681537,['SUMO1'],0.9963497212814001,0,0,1
208,Neural Crest Differentiation WP2064,0.923255898541214,0.38487265243118085,0.030731633451681537,['DLL3'],0.9963497212814001,0,0,1
209,Endoderm differentiation WP2853,0.9310607110504098,0.36875410913872453,0.026340398530243822,['NME1'],0.9963497212814001,0,0,1
210,B Cell Receptor Signaling Pathway WP23,0.9380731607573126,0.3539250493096647,0.02262548571397555,['HRAS'],0.9963497212814001,0,0,1
211,Metapathway biotransformation Phase I and II WP702,0.941343698184733,0.4309264436517883,0.02604819276041738,"['GPX4', 'GSTO1']",0.9963497212814001,0,0,2
212,Spinal Cord Injury WP2431,0.9508651315015436,0.41069951282286976,0.02069229164695536,"['BCAN', 'APEX1']",0.9963497212814001,0,0,2
213,NRF2 pathway WP2884,0.9508651315015436,0.41069951282286976,0.02069229164695536,"['FTH1', 'TXN']",0.9963497212814001,0,0,2
214,Chemokine signaling pathway WP3929,0.9596883147826915,0.3048357478065701,0.012542990959495936,['HRAS'],0.9963497212814001,0,0,1
215,Mesodermal commitment pathway WP2857,0.9596883147826915,0.3048357478065701,0.012542990959495936,['RPL38'],0.9963497212814001,0,0,1
216,Insulin Signaling WP481,0.9637927966340836,0.29460880999342537,0.010864863197893915,['HRAS'],0.9963497212814001,0,0,1
217,Hippo-Merlin Signaling Dysregulation WP4541,0.9674800794209801,0.28504167461983837,0.009423604331676614,['HRAS'],0.9963497212814001,0,0,1
218,Focal Adhesion WP306,0.9738542241275656,0.3526482213438735,0.009342939875722897,"['VEGFB', 'HRAS']",0.9963497212814001,0,0,2
219,"GPCRs, Other WP117",0.9764410368730464,0.2597169045132846,0.006191888019927391,['ADGRL2'],0.9963497212814001,0,0,1
220,PI3K-Akt signaling pathway WP4172,0.9806402407634172,0.45715291583830353,0.008937162919325635,"['RPS6', 'VEGFB', 'COL9A3', 'FGF1', 'HRAS']",0.9963497212814001,0,0,5
221,Ciliopathies WP4803,0.9809988237160135,0.24517861056322596,0.004703510996862118,['CCDC28B'],0.9963497212814001,0,0,1
222,Vitamin D Receptor Pathway WP2877,0.9834879892294187,0.3202299676607977,0.005331782048080074,"['S100A6', 'HLA-DRB1']",0.9963497212814001,0,0,2
223,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9839512331771887,0.41325863678804853,0.006686087902936031,"['RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9963497212814001,0,0,4
224,Ras signaling WP4223,0.9876428235281315,0.22046351084812624,0.0027412788423222564,['HRAS'],0.9963497212814001,0,0,1
225,Nuclear Receptors Meta-Pathway WP2882,0.989987502189132,0.3854875283446712,0.0038791455722821636,"['PSMC5', 'FTH1', 'BAX', 'TXN']",0.9963497212814001,0,0,4
226,MAPK Signaling Pathway WP382,0.99411795116619,0.2661995448556713,0.0015704219127891138,"['FGF1', 'HRAS']",0.9963497212814001,0,0,2
227,Calcium Regulation in the Cardiac Cell WP536,0.996221173101256,0.17248714081293268,0.0006530336765591385,['RGS6'],0.9963497212814001,0,0,1
228,"GPCRs, Class A Rhodopsin-like WP455",0.9963497212814001,0.2471747480933029,0.0009039074853840066,"['GPR35', 'HCRTR1']",0.9963497212814001,0,0,2
